期刊文献+

培美曲塞治疗晚期非小细胞肺癌患者不良反应的护理 被引量:10

下载PDF
导出
摘要 总结18例晚期非小细胞肺癌患者使用培美曲塞化疗不良反应的护理经验。18例患者中,1例发生药液外渗,10例出现轻度胃肠道反应,5例出现血红蛋白或白细胞下降,1例出现皮肤瘙痒,2例出现肝功能损害,转氨酶升高。加强血常规和体温检测,及时发现药物的血液毒性及时处理;给予地塞米松预防皮肤瘙痒发生;用药前及用药期间检测肝功能情况,对于肝功能异常者予护肝治疗:18例患者均能够顺利完成培美曲塞治疗。
出处 《护理学报》 2007年第1期74-75,共2页 Journal of Nursing(China)
  • 相关文献

参考文献2

二级参考文献32

  • 1[1]HANAUSKE AR,CHEN V,PAOLETTI P,et al.Pemetrexed disodium:a novel antifolate clinically active against multiple solid tumors [J].Oncologist,2001,6(4):363-373.
  • 2[2]ADJEI AA.Pemetrexed:a multitargeted antifolate agent with promising activity in solid tumors [J].Ann Oncol,2000,11(10):1335-1341.
  • 3[3]SCHULTZ RM,PATEL VF,WORZALLA JF,et al.Role of thymidylate synthase in the antitumor activity of the multitargeted antifolate,LY231514 [J].Anticancer Res,1999,19(1A):437-443.
  • 4[4]TEICHER BA,CHEN V,SHIH C,et al.Treatment regimens including the multitargeted antifolate LY231514 in human tumor xenografts.[J].Clin Cancer Res,2000,6(3):1016-1023.
  • 5[5]FOSSELLA FV,GATZEMEIER U.Phase I trials of pemetrexed [J].Semin Oncol,2002,29(2 Suppl 5):8-16.
  • 6[6]RINALDI DA,KUHN JG,BURRIS HA,et al.A phase I evaluation of multitargeted antifolate (MTA,LY231514),administered every 21 days,utilizing the modified continual reassessment method for dose escalation [J].Cancer Chemother Pharmacol,1999,44(5):372-380.
  • 7[7]THODTMANN R,DEPENBROCK H,DUMEZ,et al.Clinical and pharmacokinetic phase I study of multitargeted antifolate (LY231514) in combination with cisplatin [J].J Clin Oncol,1999,17(10):3009-3016.
  • 8[8]HUGHES A,CALVERT P,AZZABI A,et al.Phase I Clinical and Pharmacokinetic Study of Pemetrexed and Carboplatin in Patients With Malignant Pleural Mesothelioma [J].J Clin Oncol,2002,20(16):3533-3544.
  • 9[9]RUSTHOVEN JJ,EISENHAUER E,BUTTS C,et al.Targeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer:a phase II study.National Cancer Institute of Canada Clinical Trials Group [J].J Clin Oncol,1999 ,17(4):1194.
  • 10[10]CLARKE SJ,ABRATT R,GOEDHALS L,et al.Phase II trial of pemetrexed disodium (ALIMTA,LY231514) in chemotherapy-naive patients with advanced non-small-cell lung cancer [J].Ann Oncol,2002,13(5):737-741.

共引文献68

同被引文献43

引证文献10

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部